Thiopurines and Risk of Nonmelanoma Skin Cancer in Inflammatory Bowel Disease

被引：8
|
作者：
Ramiscal, Judi Anne B. [2 ]
Brewer, Jerry D. [1 ]
机构：
[1] Mayo Clin, Div Dermatol Surg, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Mayo Med Sch, Rochester, MN 55905 USA
来源：
JAMA DERMATOLOGY | 2013年 / 149卷 / 01期
关键词：
D O I：
10.1001/2013.jamadermatol.616
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：92 / 94
页数：3
相关论文
共 50 条
  • [1] Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased
    van Schaik, Fiona D. M.
    van Oijen, Martijn G. H.
    Smeets, Hugo M.
    van der Heijden, Geert J. M. G.
    Siersema, Peter D.
    Oldenburg, Bas
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (05) : 449 - 450
  • [2] Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
    Peyrin-Biroulet, Laurent
    Khosrotehrani, Kiarash
    Carrat, Fabrice
    Bouvier, Anne-Marie
    Chevaux, Jean-Baptiste
    Simon, Tabassome
    Carbonnel, Frank
    Colombel, Jean-Frederic
    Dupas, Jean-Louis
    Godeberge, Philippe
    Hugot, Jean-Pierre
    Lemann, Marc
    Nahon, Stephane
    Sabate, Jean-Marc
    Tucat, Gilbert
    Beaugerie, Laurent
    [J]. GASTROENTEROLOGY, 2011, 141 (05) : 1621 - U150
  • [3] Nonmelanoma Skin Cancer in Inflammatory Bowel Disease: A Review
    Long, Millie D.
    Kappelman, Michael D.
    Pipkin, Clare A.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 (06) : 1423 - 1427
  • [4] Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
    Long, Millie D.
    Martin, Christopher F.
    Pipkin, Clare A.
    Herfarth, Hans H.
    Sandler, Robert S.
    Kappelman, Michael D.
    [J]. GASTROENTEROLOGY, 2012, 143 (02) : 390 - +
  • [5] Nonmelanoma Skin Cancers in Inflammatory Bowel Disease Patients Treated With Thiopurines: A Systematic Review and Meta-Analysis
    Thosani, Nirav
    Mehta, Shivang
    Wolf, David S.
    Dupont, Andrew W.
    Fallon, Michael B.
    Guha, Sushovan
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S401 - S402
  • [6] No Increased Risk of Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease Using Thiopurines
    van Schaik, Fiona D.
    Smeets, Hugo M.
    van der Heijden, Geert J.
    Siersema, Peter D.
    van Oijen, Martijn G.
    Oldenburg, Bas
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S770 - S771
  • [7] Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease
    Laharie, D.
    Riviere, P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (05) : 689 - 690
  • [8] The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease
    Carrat, F.
    Seksik, P.
    Colombel, J. -F.
    Peyrin-Biroulet, L.
    Beaugerie, L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (04) : 533 - 541
  • [9] Increased Risk of Nonmelanoma Skin Cancers Among Individuals With Inflammatory Bowel Disease
    Singh, Harminder
    Nugent, Zoann
    Demers, Alain A.
    Bernstein, Charles N.
    [J]. GASTROENTEROLOGY, 2011, 141 (05) : 1612 - 1620
  • [10] The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines
    Bahi, Morwan
    Walmsley, Russell S.
    Gray, Andrew R.
    Young, David
    Hobbs, Catherine E.
    Aluzaite, Kristina
    Schultz, Michael
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (05) : 1047 - 1052
12345